REANIMACION CARDIOPULMONAR EN LA PACIENTE EMBARAZADA.pptx

•Descargar como PPTX, PDF•

0 recomendaciones•1 vista

Javier Ivan Salazar Perez

The document discusses the 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. It provides an executive summary of the guidelines written by Merchant RM, Topjian AA, Panchal AR, et al. The guidelines were published in Circulation in 2020 and focus on procedures and best practices for cardiopulmonary resuscitation and emergency cardiovascular care.

Salud y medicina

RCPENLAPACIENTE
EMBARAZADA

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

REANIMACION CARDIOPULMONAR EN LA PACIENTE EMBARAZADA.pptx

Recomendados

Taquicardia

Marina Mitshel Anguiano Diaz

The document discusses guidelines for treating tachycardia (fast heart rate) from the 2020 American Heart Association. It outlines algorithms for evaluating and treating stable versus unstable tachycardia. For stable tachycardia, treatment may include vagal maneuvers, medication like adenosine or cardioversion. Unstable tachycardia requires immediate cardioversion or treatment for underlying causes like hypotension, altered mental status or chest pain.

heart-failure-management- american CC guidelines

heart-failure-management- american CC guidelines

heart-failure-management- american CC guidelines

The 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure provides recommendations on the diagnosis and treatment of heart failure. Key points from the guideline include: - New recommendations are made for treating heart failure with preserved ejection fraction (HFpEF) with sodium-glucose cotransporter-2 inhibitors, mineralocorticoid receptor antagonists, and angiotensin receptor-neprilysin inhibitors. - Heart failure with mildly reduced ejection fraction (HFmrEF) should be treated with sodium-glucose cotransporter-2 inhibitors and other guideline-directed medical therapies. - Amyloid heart disease has new recommendations for screening and treatment.

Update of Heart failure management (1) (1).pptx

Update of Heart failure management (1) (1).pptx

Update of Heart failure management (1) (1).pptx

This document summarizes guidelines for the diagnosis and management of heart failure (HF). It defines HF as a clinical syndrome with symptoms from impaired ventricular filling or ejection of blood. HF has significant burden and stages without symptoms are not considered HF. Common causes include ischemic heart disease, hypertension, and valvular disease. Diagnosis involves history, exam, labs, imaging like echocardiogram and cardiac MRI. Treatment depends on stages and includes medications, devices, and management of underlying causes.

slide-set-heart-failure-management.pptx

slide-set-heart-failure-management.pptx

slide-set-heart-failure-management.pptx

The document provides guidelines for the management of heart failure from the American Heart Association, American College of Cardiology, and Heart Failure Society of America. It discusses recommendations for the initial clinical assessment of patients with heart failure, including obtaining a thorough history and physical examination to evaluate symptoms, signs of advanced heart failure, family history, potential causes, and comorbidities. Regular assessment of vital signs and evidence of clinical congestion is also recommended to guide ongoing medical management.

Pharmacotherapy in Chronical Systolic Heart Failure

Pharmacotherapy in Chronical Systolic Heart Failure

Pharmacotherapy in Chronical Systolic Heart Failure

This document discusses pharmacological treatment for chronic systolic heart failure. It outlines the goals of treatment as relieving symptoms and preventing hospitalization and death. It provides recommendations from guidelines for evidence-based medications including ACE inhibitors, beta-blockers, mineralocorticoid receptor antagonists, and others. It notes demonstration of benefits from randomized clinical trials including relative risk reductions in mortality from different drug classes.

Samir rafla 2019 aha focused update of the 2014 aha guideline for the managem...

Samir rafla 2019 aha focused update of the 2014 aha guideline for the managem...

Samir rafla 2019 aha focused update of the 2014 aha guideline for the managem...

Alexandria University, Egypt

Return to Play in the COVID Era

Return to Play in the COVID Era

Return to Play in the COVID Era

This document summarizes a presentation by Dr. Aaron Baggish on return to play in the COVID era. It discusses the cardiac impacts of COVID-19 including myocardial injury, cytokine storm effects, and viral invasion. It outlines the suspension of major sports leagues in March 2020 due to the pandemic. It proposes cardiac testing recommendations including symptom screening, troponin testing, and ECG or echocardiogram for athletes returning to play. Early data from the ORCCA registry shows a low prevalence of myocarditis among asymptomatic athletes. Ongoing research is needed to establish reliable cardiac screening methods for detecting COVID-related heart issues in athletes.

pie diabetico diagnostico y tratamiento.pptx

pie diabetico diagnostico y tratamiento.pptx

pie diabetico diagnostico y tratamiento.pptx

Javier Ivan Salazar Perez

El documento define el pie diabético como el pie con ulceración, infección o destrucción de los tejidos profundos asociados a alteraciones neurológicas y diversos grados de enfermedad vascular periférica. Incluye tres complicaciones principales: úlceras en el pie diabético, infecciones y pie de Charcot. Describe la evaluación, clasificación, factores de riesgo, tratamiento y prevención de las úlceras del pie diabético.

Recomendados

Taquicardia

Marina Mitshel Anguiano Diaz

The document discusses guidelines for treating tachycardia (fast heart rate) from the 2020 American Heart Association. It outlines algorithms for evaluating and treating stable versus unstable tachycardia. For stable tachycardia, treatment may include vagal maneuvers, medication like adenosine or cardioversion. Unstable tachycardia requires immediate cardioversion or treatment for underlying causes like hypotension, altered mental status or chest pain.

heart-failure-management- american CC guidelines

heart-failure-management- american CC guidelines

heart-failure-management- american CC guidelines

The 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure provides recommendations on the diagnosis and treatment of heart failure. Key points from the guideline include: - New recommendations are made for treating heart failure with preserved ejection fraction (HFpEF) with sodium-glucose cotransporter-2 inhibitors, mineralocorticoid receptor antagonists, and angiotensin receptor-neprilysin inhibitors. - Heart failure with mildly reduced ejection fraction (HFmrEF) should be treated with sodium-glucose cotransporter-2 inhibitors and other guideline-directed medical therapies. - Amyloid heart disease has new recommendations for screening and treatment.

Update of Heart failure management (1) (1).pptx

Update of Heart failure management (1) (1).pptx

Update of Heart failure management (1) (1).pptx

This document summarizes guidelines for the diagnosis and management of heart failure (HF). It defines HF as a clinical syndrome with symptoms from impaired ventricular filling or ejection of blood. HF has significant burden and stages without symptoms are not considered HF. Common causes include ischemic heart disease, hypertension, and valvular disease. Diagnosis involves history, exam, labs, imaging like echocardiogram and cardiac MRI. Treatment depends on stages and includes medications, devices, and management of underlying causes.

slide-set-heart-failure-management.pptx

slide-set-heart-failure-management.pptx

slide-set-heart-failure-management.pptx

The document provides guidelines for the management of heart failure from the American Heart Association, American College of Cardiology, and Heart Failure Society of America. It discusses recommendations for the initial clinical assessment of patients with heart failure, including obtaining a thorough history and physical examination to evaluate symptoms, signs of advanced heart failure, family history, potential causes, and comorbidities. Regular assessment of vital signs and evidence of clinical congestion is also recommended to guide ongoing medical management.

Pharmacotherapy in Chronical Systolic Heart Failure

Pharmacotherapy in Chronical Systolic Heart Failure

Pharmacotherapy in Chronical Systolic Heart Failure

This document discusses pharmacological treatment for chronic systolic heart failure. It outlines the goals of treatment as relieving symptoms and preventing hospitalization and death. It provides recommendations from guidelines for evidence-based medications including ACE inhibitors, beta-blockers, mineralocorticoid receptor antagonists, and others. It notes demonstration of benefits from randomized clinical trials including relative risk reductions in mortality from different drug classes.

Samir rafla 2019 aha focused update of the 2014 aha guideline for the managem...

Samir rafla 2019 aha focused update of the 2014 aha guideline for the managem...

Samir rafla 2019 aha focused update of the 2014 aha guideline for the managem...

Alexandria University, Egypt

Return to Play in the COVID Era

Return to Play in the COVID Era

Return to Play in the COVID Era

This document summarizes a presentation by Dr. Aaron Baggish on return to play in the COVID era. It discusses the cardiac impacts of COVID-19 including myocardial injury, cytokine storm effects, and viral invasion. It outlines the suspension of major sports leagues in March 2020 due to the pandemic. It proposes cardiac testing recommendations including symptom screening, troponin testing, and ECG or echocardiogram for athletes returning to play. Early data from the ORCCA registry shows a low prevalence of myocarditis among asymptomatic athletes. Ongoing research is needed to establish reliable cardiac screening methods for detecting COVID-related heart issues in athletes.

pie diabetico diagnostico y tratamiento.pptx

pie diabetico diagnostico y tratamiento.pptx

pie diabetico diagnostico y tratamiento.pptx

Javier Ivan Salazar Perez

El documento define el pie diabético como el pie con ulceración, infección o destrucción de los tejidos profundos asociados a alteraciones neurológicas y diversos grados de enfermedad vascular periférica. Incluye tres complicaciones principales: úlceras en el pie diabético, infecciones y pie de Charcot. Describe la evaluación, clasificación, factores de riesgo, tratamiento y prevención de las úlceras del pie diabético.

insuficienciavenosa-110929150720-phpapp02.pptx

insuficienciavenosa-110929150720-phpapp02.pptx

insuficienciavenosa-110929150720-phpapp02.pptx

Javier Ivan Salazar Perez

El documento describe la insuficiencia venosa, incluyendo su definición, causas, síntomas y tratamiento. La insuficiencia venosa puede ser aguda (trombosis venosa) o crónica y se debe a la obstrucción del drenaje venoso o reflujo. El síndrome posflebítico es un efecto adverso tardío de la trombosis venosa profunda que causa lesión permanente de las válvulas venosas. El tratamiento inicial para cualquier trastorno venoso es conservador.

Reanimación cardiopulmonar HCJIM Obstetricia

Reanimación cardiopulmonar HCJIM Obstetricia

Reanimación cardiopulmonar HCJIM Obstetricia

Javier Ivan Salazar Perez

El documento habla sobre la reanimación cardiopulmonar (RCP) y el soporte vital cardiovascular avanzado (ACLS). Explica los diferentes ritmos cardíacos que pueden ocurrir durante un paro cardíaco como la fibrilación ventricular, la taquicardia ventricular sin pulso y la asistolia, así como sus posibles causas y tratamientos. También describe los procedimientos de RCP como la desfibrilación, la administración de medicamentos como la adrenalina, y consideraciones especiales como la RCP en una mujer embarazada.

Copia de Expo weaning.pptx

Copia de Expo weaning.pptx

Copia de Expo weaning.pptx

Javier Ivan Salazar Perez

Este documento describe el proceso de liberación de la ventilación mecánica, incluyendo predictores de éxito y fracaso, protocolos de retiro, criterios necesarios para las pruebas de ventilación espontánea y criterios de éxito. Aborda factores como la variabilidad de la frecuencia cardíaca, la fuerza de agarre, la disfunción diafragmática y los marcadores de estrés oxidativo que pueden predecir el resultado del destete. También compara estrategias como la pieza en T versus la ventilación con soporte de pres

Teorico_VIA_AEREA.pptx

Teorico_VIA_AEREA.pptx

Teorico_VIA_AEREA.pptx

Javier Ivan Salazar Perez

Bienestar de profesores y estudiantes en el ambiente educativo. Dr Salazar.pptx

Bienestar de profesores y estudiantes en el ambiente educativo. Dr Salazar.pptx

Bienestar de profesores y estudiantes en el ambiente educativo. Dr Salazar.pptx

Javier Ivan Salazar Perez

Este documento discute el bienestar de profesores y estudiantes en el ambiente educativo. Aborda conceptos como salud, salud mental, ansiedad, depresión y síndrome de burnout en docentes universitarios. También analiza factores asociados a problemas de salud mental como sobrecarga académica y estudiantes difíciles. Finalmente, propone estrategias de prevención como detección temprana, apoyo para reducir sobrecarga y capacitación de docentes.

PIRETRINAS_Y_PIRETROIDES.pptx

PIRETRINAS_Y_PIRETROIDES.pptx

PIRETRINAS_Y_PIRETROIDES.pptx

Javier Ivan Salazar Perez

Los piretroides e insecticidas similares son populares debido a su baja persistencia y resistencia. Sin embargo, pueden causar efectos adversos como temblores, hiperexcitabilidad y convulsiones al entrar en contacto con la piel o ser inhalados. El diagnóstico se basa en la historia clínica y exámenes pueden detectar residuos en la orina. El tratamiento incluye descontaminación de la piel, carbón activado para ingestión y medicamentos antihistamínicos para reacciones alérgicas.

Hemorragias en 2da mitad del embarazo.pptx

Hemorragias en 2da mitad del embarazo.pptx

Hemorragias en 2da mitad del embarazo.pptx

Javier Ivan Salazar Perez

CRISIS DE ANSIEDAD PRESENTANCION PRACTICANTES DE PSICOLOGIA UTEG.pptx

CRISIS DE ANSIEDAD PRESENTANCION PRACTICANTES DE PSICOLOGIA UTEG.pptx

CRISIS DE ANSIEDAD PRESENTANCION PRACTICANTES DE PSICOLOGIA UTEG.pptx

Javier Ivan Salazar Perez

Este documento describe las crisis de ansiedad, incluyendo sus síntomas y tipos de trastornos de ansiedad. Explica que una crisis de ansiedad es un episodio repentino de preocupaciones e intensos miedos ante situaciones cotidianas. También proporciona consejos para ayudar a alguien que está teniendo una crisis de ansiedad, como mantener la calma, hablar con frases cortas y ayudar a controlar la respiración.

Enfermedades respiratorias pediatria UA HCFAA.pptx

Enfermedades respiratorias pediatria UA HCFAA.pptx

Enfermedades respiratorias pediatria UA HCFAA.pptx

Javier Ivan Salazar Perez

1. El documento describe las guías y criterios para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad en pediatría. 2. El diagnóstico es fundamentalmente clínico basado en síntomas como fiebre, tos y dificultad respiratoria así como hallazgos auscultatorios, aunque existen incertidumbres sobre los criterios radiológicos. 3. El tratamiento antibiótico empírico depende de factores como la edad del paciente, gravedad de los síntomas y situ

TIEMPOS QUIRÚRGICOS FUNDAMENTALES.pptx

TIEMPOS QUIRÚRGICOS FUNDAMENTALES.pptx

TIEMPOS QUIRÚRGICOS FUNDAMENTALES.pptx

Javier Ivan Salazar Perez

Conferencia te toca tocarte.pptx

Conferencia te toca tocarte.pptx

Conferencia te toca tocarte.pptx

Javier Ivan Salazar Perez

Resucitacion fluida Urgencias HCFAA.pptx

Resucitacion fluida Urgencias HCFAA.pptx

Resucitacion fluida Urgencias HCFAA.pptx

Javier Ivan Salazar Perez

Este documento discute los principios fundamentales de la reanimación con fluidos. Resalta que los cristaloides equilibrados ofrecen solo beneficios mínimos sobre la solución salina normal y que los coloides no mejoran los resultados para los pacientes. Recomienda enfocarse en el volumen de líquido administrado usando principalmente cristaloides intravenosos. También destaca la importancia de la fisiología del retorno venoso y el uso temprano de vasopresores de baja dosis para aumentar el tono venoso y limitar el volumen de

SALUD SEXUAL.pptx

SALUD SEXUAL.pptx

SALUD SEXUAL.pptx

Javier Ivan Salazar Perez

Este documento resume las principales enfermedades de transmisión sexual, incluyendo el agente causante, síntomas, diagnóstico y tratamiento de cada una. Describe enfermedades bacterianas como la sífilis, chancroide y granuloma inguinal, causadas por Treponema pallidum, Haemophilus ducreyi y Klebsiella granulomatis respectivamente. También describe infecciones virales como el herpes genital y el molusco contagioso, causados por los virus del herpes simplex y del molusco. Por último, explica paras

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach

Ayurveda ForAll

Efficacy of Avartana Sneha in Ayurveda

Efficacy of Avartana Sneha in Ayurveda

Efficacy of Avartana Sneha in Ayurveda

Dr. Jyothirmai Paindla

Complementary feeding in infant IAP PROTOCOLS

Complementary feeding in infant IAP PROTOCOLS

Complementary feeding in infant IAP PROTOCOLS

chiranthgowda16

The Electrocardiogram - Physiologic Principles

The Electrocardiogram - Physiologic Principles

The Electrocardiogram - Physiologic Principles

MedicoseAcademics

These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram. Learning objectives: 1. Define an electrocardiogram (ECG) and electrocardiography 2. Describe how dipoles generated by the heart produce the waveforms of the ECG 3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II) 4. Differentiate between intervals and segments 5. Enlist some common indications for obtaining an ECG 6. Describe the flow of current around the heart during the cardiac cycle 7. Discuss the placement and polarity of the leads of electrocardiograph 8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained 9. Define mean electrical vector (axis) of the heart and give the normal range 10. Define the mean QRS vector 11. Describe the axes of leads (hexagonal reference system) 12. Comprehend the vectorial analysis of the normal ECG 13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation 14. Explain the concepts of current of injury, J point, and their significance Study Resources: 1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition 2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition 3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition 4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/ 5. ECG in Medical Practice by ABM Abdullah, 4th edition 6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/ 7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

NephroTube - Dr.Gawad

- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ - Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0 - Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html - Link to NephroTube website: www.NephroTube.com - Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...

Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

Más contenido relacionado

Más de Javier Ivan Salazar Perez

insuficienciavenosa-110929150720-phpapp02.pptx

insuficienciavenosa-110929150720-phpapp02.pptx

insuficienciavenosa-110929150720-phpapp02.pptx

Javier Ivan Salazar Perez

El documento describe la insuficiencia venosa, incluyendo su definición, causas, síntomas y tratamiento. La insuficiencia venosa puede ser aguda (trombosis venosa) o crónica y se debe a la obstrucción del drenaje venoso o reflujo. El síndrome posflebítico es un efecto adverso tardío de la trombosis venosa profunda que causa lesión permanente de las válvulas venosas. El tratamiento inicial para cualquier trastorno venoso es conservador.

Reanimación cardiopulmonar HCJIM Obstetricia

Reanimación cardiopulmonar HCJIM Obstetricia

Reanimación cardiopulmonar HCJIM Obstetricia

Javier Ivan Salazar Perez

El documento habla sobre la reanimación cardiopulmonar (RCP) y el soporte vital cardiovascular avanzado (ACLS). Explica los diferentes ritmos cardíacos que pueden ocurrir durante un paro cardíaco como la fibrilación ventricular, la taquicardia ventricular sin pulso y la asistolia, así como sus posibles causas y tratamientos. También describe los procedimientos de RCP como la desfibrilación, la administración de medicamentos como la adrenalina, y consideraciones especiales como la RCP en una mujer embarazada.

Copia de Expo weaning.pptx

Copia de Expo weaning.pptx

Copia de Expo weaning.pptx

Javier Ivan Salazar Perez

Este documento describe el proceso de liberación de la ventilación mecánica, incluyendo predictores de éxito y fracaso, protocolos de retiro, criterios necesarios para las pruebas de ventilación espontánea y criterios de éxito. Aborda factores como la variabilidad de la frecuencia cardíaca, la fuerza de agarre, la disfunción diafragmática y los marcadores de estrés oxidativo que pueden predecir el resultado del destete. También compara estrategias como la pieza en T versus la ventilación con soporte de pres

Teorico_VIA_AEREA.pptx

Teorico_VIA_AEREA.pptx

Teorico_VIA_AEREA.pptx

Javier Ivan Salazar Perez

Bienestar de profesores y estudiantes en el ambiente educativo. Dr Salazar.pptx

Bienestar de profesores y estudiantes en el ambiente educativo. Dr Salazar.pptx

Bienestar de profesores y estudiantes en el ambiente educativo. Dr Salazar.pptx

Javier Ivan Salazar Perez

Este documento discute el bienestar de profesores y estudiantes en el ambiente educativo. Aborda conceptos como salud, salud mental, ansiedad, depresión y síndrome de burnout en docentes universitarios. También analiza factores asociados a problemas de salud mental como sobrecarga académica y estudiantes difíciles. Finalmente, propone estrategias de prevención como detección temprana, apoyo para reducir sobrecarga y capacitación de docentes.

PIRETRINAS_Y_PIRETROIDES.pptx

PIRETRINAS_Y_PIRETROIDES.pptx

PIRETRINAS_Y_PIRETROIDES.pptx

Javier Ivan Salazar Perez

Los piretroides e insecticidas similares son populares debido a su baja persistencia y resistencia. Sin embargo, pueden causar efectos adversos como temblores, hiperexcitabilidad y convulsiones al entrar en contacto con la piel o ser inhalados. El diagnóstico se basa en la historia clínica y exámenes pueden detectar residuos en la orina. El tratamiento incluye descontaminación de la piel, carbón activado para ingestión y medicamentos antihistamínicos para reacciones alérgicas.

Hemorragias en 2da mitad del embarazo.pptx

Hemorragias en 2da mitad del embarazo.pptx

Hemorragias en 2da mitad del embarazo.pptx

Javier Ivan Salazar Perez

CRISIS DE ANSIEDAD PRESENTANCION PRACTICANTES DE PSICOLOGIA UTEG.pptx

CRISIS DE ANSIEDAD PRESENTANCION PRACTICANTES DE PSICOLOGIA UTEG.pptx

CRISIS DE ANSIEDAD PRESENTANCION PRACTICANTES DE PSICOLOGIA UTEG.pptx

Javier Ivan Salazar Perez

Este documento describe las crisis de ansiedad, incluyendo sus síntomas y tipos de trastornos de ansiedad. Explica que una crisis de ansiedad es un episodio repentino de preocupaciones e intensos miedos ante situaciones cotidianas. También proporciona consejos para ayudar a alguien que está teniendo una crisis de ansiedad, como mantener la calma, hablar con frases cortas y ayudar a controlar la respiración.

Enfermedades respiratorias pediatria UA HCFAA.pptx

Enfermedades respiratorias pediatria UA HCFAA.pptx

Enfermedades respiratorias pediatria UA HCFAA.pptx

Javier Ivan Salazar Perez

1. El documento describe las guías y criterios para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad en pediatría. 2. El diagnóstico es fundamentalmente clínico basado en síntomas como fiebre, tos y dificultad respiratoria así como hallazgos auscultatorios, aunque existen incertidumbres sobre los criterios radiológicos. 3. El tratamiento antibiótico empírico depende de factores como la edad del paciente, gravedad de los síntomas y situ

TIEMPOS QUIRÚRGICOS FUNDAMENTALES.pptx

TIEMPOS QUIRÚRGICOS FUNDAMENTALES.pptx

TIEMPOS QUIRÚRGICOS FUNDAMENTALES.pptx

Javier Ivan Salazar Perez

Conferencia te toca tocarte.pptx

Conferencia te toca tocarte.pptx

Conferencia te toca tocarte.pptx

Javier Ivan Salazar Perez

Resucitacion fluida Urgencias HCFAA.pptx

Resucitacion fluida Urgencias HCFAA.pptx

Resucitacion fluida Urgencias HCFAA.pptx

Javier Ivan Salazar Perez

Este documento discute los principios fundamentales de la reanimación con fluidos. Resalta que los cristaloides equilibrados ofrecen solo beneficios mínimos sobre la solución salina normal y que los coloides no mejoran los resultados para los pacientes. Recomienda enfocarse en el volumen de líquido administrado usando principalmente cristaloides intravenosos. También destaca la importancia de la fisiología del retorno venoso y el uso temprano de vasopresores de baja dosis para aumentar el tono venoso y limitar el volumen de

SALUD SEXUAL.pptx

SALUD SEXUAL.pptx

SALUD SEXUAL.pptx

Javier Ivan Salazar Perez

Este documento resume las principales enfermedades de transmisión sexual, incluyendo el agente causante, síntomas, diagnóstico y tratamiento de cada una. Describe enfermedades bacterianas como la sífilis, chancroide y granuloma inguinal, causadas por Treponema pallidum, Haemophilus ducreyi y Klebsiella granulomatis respectivamente. También describe infecciones virales como el herpes genital y el molusco contagioso, causados por los virus del herpes simplex y del molusco. Por último, explica paras

Más de Javier Ivan Salazar Perez (13)

insuficienciavenosa-110929150720-phpapp02.pptx

insuficienciavenosa-110929150720-phpapp02.pptx

insuficienciavenosa-110929150720-phpapp02.pptx

Reanimación cardiopulmonar HCJIM Obstetricia

Reanimación cardiopulmonar HCJIM Obstetricia

Reanimación cardiopulmonar HCJIM Obstetricia

Copia de Expo weaning.pptx

Copia de Expo weaning.pptx

Copia de Expo weaning.pptx

Teorico_VIA_AEREA.pptx

Teorico_VIA_AEREA.pptx

Teorico_VIA_AEREA.pptx

Bienestar de profesores y estudiantes en el ambiente educativo. Dr Salazar.pptx

Bienestar de profesores y estudiantes en el ambiente educativo. Dr Salazar.pptx

Bienestar de profesores y estudiantes en el ambiente educativo. Dr Salazar.pptx

PIRETRINAS_Y_PIRETROIDES.pptx

PIRETRINAS_Y_PIRETROIDES.pptx

PIRETRINAS_Y_PIRETROIDES.pptx

Hemorragias en 2da mitad del embarazo.pptx

Hemorragias en 2da mitad del embarazo.pptx

Hemorragias en 2da mitad del embarazo.pptx

CRISIS DE ANSIEDAD PRESENTANCION PRACTICANTES DE PSICOLOGIA UTEG.pptx

CRISIS DE ANSIEDAD PRESENTANCION PRACTICANTES DE PSICOLOGIA UTEG.pptx

CRISIS DE ANSIEDAD PRESENTANCION PRACTICANTES DE PSICOLOGIA UTEG.pptx

Enfermedades respiratorias pediatria UA HCFAA.pptx

Enfermedades respiratorias pediatria UA HCFAA.pptx

Enfermedades respiratorias pediatria UA HCFAA.pptx

TIEMPOS QUIRÚRGICOS FUNDAMENTALES.pptx

TIEMPOS QUIRÚRGICOS FUNDAMENTALES.pptx

TIEMPOS QUIRÚRGICOS FUNDAMENTALES.pptx

Conferencia te toca tocarte.pptx

Conferencia te toca tocarte.pptx

Conferencia te toca tocarte.pptx

Resucitacion fluida Urgencias HCFAA.pptx

Resucitacion fluida Urgencias HCFAA.pptx

Resucitacion fluida Urgencias HCFAA.pptx

SALUD SEXUAL.pptx

SALUD SEXUAL.pptx

SALUD SEXUAL.pptx

Último

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach

Ayurveda ForAll

Efficacy of Avartana Sneha in Ayurveda

Efficacy of Avartana Sneha in Ayurveda

Efficacy of Avartana Sneha in Ayurveda

Dr. Jyothirmai Paindla

Complementary feeding in infant IAP PROTOCOLS

Complementary feeding in infant IAP PROTOCOLS

Complementary feeding in infant IAP PROTOCOLS

chiranthgowda16

The Electrocardiogram - Physiologic Principles

The Electrocardiogram - Physiologic Principles

The Electrocardiogram - Physiologic Principles

MedicoseAcademics

These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram. Learning objectives: 1. Define an electrocardiogram (ECG) and electrocardiography 2. Describe how dipoles generated by the heart produce the waveforms of the ECG 3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II) 4. Differentiate between intervals and segments 5. Enlist some common indications for obtaining an ECG 6. Describe the flow of current around the heart during the cardiac cycle 7. Discuss the placement and polarity of the leads of electrocardiograph 8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained 9. Define mean electrical vector (axis) of the heart and give the normal range 10. Define the mean QRS vector 11. Describe the axes of leads (hexagonal reference system) 12. Comprehend the vectorial analysis of the normal ECG 13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation 14. Explain the concepts of current of injury, J point, and their significance Study Resources: 1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition 2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition 3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition 4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/ 5. ECG in Medical Practice by ABM Abdullah, 4th edition 6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/ 7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

NephroTube - Dr.Gawad

- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ - Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0 - Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html - Link to NephroTube website: www.NephroTube.com - Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...

Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

Osteoporosis - Definition , Evaluation and Management .pdf

Osteoporosis - Definition , Evaluation and Management .pdf

Osteoporosis - Definition , Evaluation and Management .pdf

Role of Mukta Pishti in the Management of Hyperthyroidism

Role of Mukta Pishti in the Management of Hyperthyroidism

Role of Mukta Pishti in the Management of Hyperthyroidism

Dr. Jyothirmai Paindla

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1

Aortic Association CBL Pilot April 19 – 20 Bern

Aortic Association CBL Pilot April 19 – 20 Bern

Aortic Association CBL Pilot April 19 – 20 Bern

Abortion PG Seminar Power point presentation

Abortion PG Seminar Power point presentation

Abortion PG Seminar Power point presentation

AksshayaRajanbabu

Artificial Intelligence Symposium (THAIS)

Artificial Intelligence Symposium (THAIS)

Artificial Intelligence Symposium (THAIS)

Josep Vidal-Alaball

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes

PsychoTech Services

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad

NephroTube - Dr.Gawad

- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0 - Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc - Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html - Link to NephroTube website: www.NephroTube.com - Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html

Hiranandani Hospital Powai News [Read Now].pdf

Hiranandani Hospital Powai News [Read Now].pdf

Hiranandani Hospital Powai News [Read Now].pdf

Dr. Sujit Chatterjee CEO Hiranandani Hospital

Hiranandani Hospital in Powai, Mumbai, is a premier healthcare institution that has been serving the community with exceptional medical care since its establishment. As a part of the renowned Hiranandani Group, the hospital is committed to delivering world-class healthcare services across a wide range of specialties, including kidney transplantation. With its state-of-the-art facilities, advanced medical technology, and a team of highly skilled healthcare professionals, Hiranandani Hospital has earned a reputation as a trusted name in the healthcare industry. The hospital's patient-centric approach, coupled with its focus on innovation and excellence, ensures that patients receive the highest standard of care in a compassionate and supportive environment.

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf

share - Lions, tigers, AI and health misinformation, oh my!.pptx

share - Lions, tigers, AI and health misinformation, oh my!.pptx

share - Lions, tigers, AI and health misinformation, oh my!.pptx

• Pitfalls and pivots needed to use AI effectively in public health • Evidence-based strategies to address health misinformation effectively • Building trust with communities online and offline • Equipping health professionals to address questions, concerns and health misinformation • Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system

Último (20)

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx

Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach

Efficacy of Avartana Sneha in Ayurveda

Efficacy of Avartana Sneha in Ayurveda

Efficacy of Avartana Sneha in Ayurveda

Complementary feeding in infant IAP PROTOCOLS

Complementary feeding in infant IAP PROTOCOLS

Complementary feeding in infant IAP PROTOCOLS

The Electrocardiogram - Physiologic Principles

The Electrocardiogram - Physiologic Principles

The Electrocardiogram - Physiologic Principles

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

Osteoporosis - Definition , Evaluation and Management .pdf

Osteoporosis - Definition , Evaluation and Management .pdf

Osteoporosis - Definition , Evaluation and Management .pdf

Role of Mukta Pishti in the Management of Hyperthyroidism

Role of Mukta Pishti in the Management of Hyperthyroidism

Role of Mukta Pishti in the Management of Hyperthyroidism

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1

Aortic Association CBL Pilot April 19 – 20 Bern

Aortic Association CBL Pilot April 19 – 20 Bern

Aortic Association CBL Pilot April 19 – 20 Bern

Abortion PG Seminar Power point presentation

Abortion PG Seminar Power point presentation

Abortion PG Seminar Power point presentation

Artificial Intelligence Symposium (THAIS)

Artificial Intelligence Symposium (THAIS)

Artificial Intelligence Symposium (THAIS)

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad

Hiranandani Hospital Powai News [Read Now].pdf

Hiranandani Hospital Powai News [Read Now].pdf

Hiranandani Hospital Powai News [Read Now].pdf

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf

share - Lions, tigers, AI and health misinformation, oh my!.pptx

share - Lions, tigers, AI and health misinformation, oh my!.pptx

share - Lions, tigers, AI and health misinformation, oh my!.pptx

REANIMACION CARDIOPULMONAR EN LA PACIENTE EMBARAZADA.pptx

1. RCPENLAPACIENTE EMBARAZADA

2.

3. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

4. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

5. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

6. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

7. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

8. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

9. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

10. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

11. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

12. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

13. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

14. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

15. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

16. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

17. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

18. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

19. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

20. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

21. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

22. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

23. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press

24.

25. Merchant RM, Topjian AA, Panchal AR, et al. Part 1: executive summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2): In press